NEW YORK, April 1 - Lynx Therapeutics and Aventis CropScience will co-develop and commercialize an assay based on Lynx's bead-based technologies, the companies said today.
Terms of the collaboration, which extends by five years a deal the firms inked in March 1999 that gave the German ag-bio firm access to Lynx's genomics-discovery services, will give the companies joint ownership of the assay technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.